Johan van Meerloo
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA Interference and Gene Delivery
- Histone Deacetylase Inhibitors Research
Papers in
-
- Ubiquitin and proteasome pathways 17
- Protein Degradation and Inhibitors 9
- Histone Deacetylase Inhibitors Research 2
- Hematology 10
- Multiple Myeloma Research and Treatments 9
- Acute Myeloid Leukemia Research 3
- Co-authors
- Jacqueline Cloos (20 shared papers)Gertjan J.L. Kaspers (16 shared papers)Gerrit Jansen (19 shared papers)Sonja Zweegman (16 shared papers)Yehuda G. Assaraf (14 shared papers)Denise Niewerth (12 shared papers)Christopher J. Kirk (9 shared papers)Aaron D. Schimmer (4 shared papers)
- Journals
- Blood (5 papers)Molecular & Cellular Proteomics (2 papers)Biochemical Pharmacology (2 papers)Cells (2 papers)Journal of Hematology & Oncology (2 papers)
- Partner nations
- NetherlandsIsraelUnited States
In The Last Decade
Johan van Meerloo
23 papers receiving 2.7k citations
Johan van Meerloo's Hit Papers
Peers
Comparison fields: 5 of 135
- Hematology 332
- Molecular Biology 1.3k
- Oncology 479
- Toxicology 59
- Biochemistry 95
Countries citing papers authored by Johan van Meerloo
This map shows the geographic impact of Johan van Meerloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan van Meerloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan van Meerloo more than expected).
Fields of papers citing papers by Johan van Meerloo
This network shows the impact of papers produced by Johan van Meerloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan van Meerloo. The network helps show where Johan van Meerloo may publish in the future.
Co-authors
The 25 scholars most cited alongside Johan van Meerloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cell Sensitivity Assays: The MTT Assay Hit paper breakdown → | 2011 | 1899 |
| 2 | 2011 | 137 | |
| 3 | 2017 | 119 | |
| 4 | 2016 | 80 | |
| 5 | 2010 | 75 | |
| 6 | 2014 | 65 | |
| 7 | 2011 | 64 | |
| 8 | 2013 | 54 | |
| 9 | 2014 | 40 | |
| 10 | 2014 | 38 | |
| 11 | 2020 | 30 | |
| 12 | 2017 | 27 | |
| 13 | 2016 | 21 | |
| 14 | 2016 | 17 | |
| 15 | 2013 | 16 | |
| 16 | 2021 | 10 | |
| 17 | 2020 | 7 | |
| 18 | 2023 | 5 | |
| 19 | 2011 | 2 | |
| 20 | 2025 | 1 |
About Johan van Meerloo
Johan van Meerloo is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Public Health, Environmental and Occupational Health, having authored 24 papers that have together received 2.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (17 papers), Protein Degradation and Inhibitors (9 papers), Multiple Myeloma Research and Treatments (9 papers), Peptidase Inhibition and Analysis (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Hematology (332 citations), Molecular Biology (1.3k citations), Oncology (479 citations), Toxicology (59 citations) and Biochemistry (95 citations). Johan van Meerloo has collaborated with scholars based in Netherlands, Israel and United States. Frequent co-authors include Jacqueline Cloos, Gertjan J.L. Kaspers, Gerrit Jansen, Sonja Zweegman, Yehuda G. Assaraf, Denise Niewerth, Christopher J. Kirk, Aaron D. Schimmer, N. Franke and Janet L. Anderl. Their work appears in journals such as Blood, Molecular & Cellular Proteomics, Biochemical Pharmacology, Cells and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.